TRIM47 and cancer: In mammals, Trim47 functions as a multifunctional regulator, driving tumor progression through ubiquitin-dependent proteolysis and oncogenic signaling while participating in inflammatory and immune pathways, positioning it as a therapeutic target in cancer (25–27).